The novel approach of the medication represents a major development in the handling of the condition. Different to existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment